Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 93, Issue 4, Pages 546-548Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/bjo.2007.133173
Keywords
-
Categories
Funding
- Stan and Madelle Rosenfeld Family Trust
Ask authors/readers for more resources
Rituximab may be effective in the treatment of ocular inflammatory disease. Dosing is less frequent than many medications currently available. Four cases are reported, each of which appeared to have responded well to treatment with rituximab, although patient 2 was able to remain on a low dose of prednisone for only 2 months. The ongoing pilot study will hopefully provide additional insight into the benefit of rituximab for treatment of scleritis and idiopathic orbital inflammatory disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available